Guggenheim Capital’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.32M | Buy |
35,139
+3,817
| +12% | +$243K | 0.02% | 655 |
|
|
2025
Q4 | $1.99M | Buy |
31,322
+440
| +1% | +$27.4K | 0.01% | 674 |
|
|
2025
Q3 | $1.7M | Sell |
30,882
-7,030
| -19% | -$290K | 0.01% | 726 |
|
|
2025
Q2 | $1.25M | Buy |
37,912
+1,209
| +3% | +$42.1K | 0.01% | 805 |
|
|
2025
Q1 | $1.48M | Buy |
36,703
+715
| +2% | +$32.9K | 0.01% | 732 |
|
|
2024
Q4 | $1.69M | Sell |
35,988
-4,898
| -12% | -$254K | 0.01% | 710 |
|
|
2024
Q3 | $2.16M | Sell |
40,886
-234
| -0.6% | -$13K | 0.02% | 802 |
|
|
2024
Q2 | $2.23M | Sell |
41,120
-548
| -1% | -$33.1K | 0.02% | 781 |
|
|
2024
Q1 | $2.92M | Sell |
41,668
-2,554
| -6% | -$198K | 0.02% | 752 |
|
|
2023
Q4 | $3.69M | Sell |
44,222
-6,780
| -13% | -$246K | 0.03% | 631 |
|
|
2023
Q3 | $1.5M | Sell |
51,002
-1,173
| -2% | -$39.1K | 0.01% | 924 |
|
|
2023
Q2 | $1.7M | Buy |
52,175
+1,219
| +2% | +$45.1K | 0.01% | 930 |
|
|
2023
Q1 | $1.79M | Sell |
50,956
-7,756
| -13% | -$316K | 0.02% | 889 |
|
|
2022
Q4 | $2.69M | Buy |
58,712
+22,670
| +63% | +$975K | 0.02% | 741 |
|
|
2022
Q3 | $1.75M | Buy |
+36,042
| New | +$1.73M | 0.02% | 888 |
|
|
2021
Q2 | – | Sell |
-9,410
| Closed | -$219K | – | 2192 |
|
|
2021
Q1 | $219K | Sell |
9,410
-9,365
| -50% | -$200K | ﹤0.01% | 2058 |
|
|
2020
Q4 | $390K | Buy |
+18,775
| New | +$343K | ﹤0.01% | 1739 |
|
|
2017
Q4 | – | Sell |
-123,456
| Closed | -$1.79M | – | 2731 |
|
|
2017
Q3 | $1.79M | Buy |
123,456
+10,201
| +9% | +$139K | ﹤0.01% | 1752 |
|
|
2017
Q2 | $1.37M | Buy |
+113,255
| New | +$1.57M | ﹤0.01% | 1882 |
|
|
2014
Q3 | – | Sell |
-17,607
| Closed | -$84K | – | 3016 |
|
|
2014
Q2 | $84K | Sell |
17,607
-290
| -2% | -$1.77K | ﹤0.01% | 3029 |
|
|
2014
Q1 | $170K | Buy |
17,897
+5,262
| +42% | +$47.6K | ﹤0.01% | 2926 |
|
|
2013
Q4 | $82K | Buy |
12,635
+1,693
| +15% | +$11.1K | ﹤0.01% | 3010 |
|
|
2013
Q3 | $83K | Buy |
+10,942
| New | +$117K | ﹤0.01% | 2874 |
|
Other funds holding CYTK
VPM
VCM
ACA
